Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Myc proto-oncogene protein | ||
Ligand | BDBM50579853 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_2145528 (CHEMBL5029808) | ||
IC50 | 0.700000±n/a nM | ||
Citation | Hill, MD; Quesnelle, C; Tokarski, J; Fang, H; Fanslau, C; Haarhoff, Z; Kramer, M; Madari, S; Wiebesiek, A; Morrison, J; Simmermacher-Mayer, J; Sinz, M; Westhouse, R; Xie, C; Zhao, J; Huang, L; Sheriff, S; Yan, C; Marsilio, F; Everlof, G; Zvyaga, T; Lee, F; Gavai, AV; Degnan, AP Development of BET inhibitors as potential treatments for cancer: A new carboline chemotype. Bioorg Med Chem Lett51:0 (2021) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Myc proto-oncogene protein | |||
Name: | Myc proto-oncogene protein | ||
Synonyms: | BHLHE39 | Class E basic helix-loop-helix protein 39 | MYC | MYC_HUMAN | Proto-oncogene c-Myc | Transcription factor p64 | ||
Type: | PROTEIN | ||
Mol. Mass.: | 48794.95 | ||
Organism: | Homo sapiens (Human) | ||
Description: | ChEMBL_935266 | ||
Residue: | 439 | ||
Sequence: |
| ||
BDBM50579853 | |||
n/a | |||
Name | BDBM50579853 | ||
Synonyms: | CHEMBL5075294 | ||
Type | Small organic molecule | ||
Emp. Form. | C27H28F2N6O | ||
Mol. Mass. | 493.5661 | ||
SMILES | [2H]C([2H])([2H])c1nnn(C)c1-c1cc2n([C@@H](CCC)c3ncccc3F)c3cc(cnc3c2cc1F)C(C)(C)O |r,wD:14.18,(54.77,-34.94,;56.32,-34.94,;57.07,-36.27,;55.78,-36.06,;57.04,-33.58,;58.57,-33.38,;58.84,-31.86,;57.49,-31.13,;57.28,-29.61,;56.38,-32.2,;54.86,-31.93,;53.87,-33.1,;52.35,-32.82,;51.14,-33.77,;51.2,-35.31,;49.89,-36.12,;48.54,-35.4,;47.23,-36.21,;52.55,-36.03,;53.85,-35.22,;55.21,-35.93,;55.27,-37.48,;53.96,-38.3,;52.6,-37.57,;51.29,-38.38,;49.87,-32.9,;48.39,-33.26,;47.33,-32.16,;47.76,-30.69,;49.25,-30.33,;50.3,-31.44,;51.84,-31.37,;52.83,-30.2,;54.34,-30.47,;55.33,-29.29,;45.84,-32.53,;45.41,-34.01,;44.34,-32.93,;44.77,-31.42,)| | ||
Structure |